25Schools
University revision · Immunology

Tumour Antigens

This topic explores the fundamental concepts of tumour antigens, which are critical in understanding cancer immunology at a tertiary level. Tumour antigens are classified into Tumour-Specific Transplantation Antigens (TSTAs) and Tumour-Associated Transplantation Antigens (TATAs), each with distinct origins and immunological implications. TSTAs arise from mutations in proto-oncogenes and tumour suppressor genes, making them unique to cancer cells, while TATAs are often reactivated embryonic proteins or overexpressed normal proteins. For Zambian university and college students pursuing degrees in Biomedical Sciences, Immunology, or related fields, mastering this topic is essential for excelling in examinations and understanding advanced cancer therapies. The content aligns with the University of Zambia's BMS 3325 Immunology syllabus and prepares learners for professional assessments in oncology and immunopathology. Knowledge of tumour antigens is pivotal for grasping how the immune system recognizes cancers and forms the basis for modern immunotherapies, which are increasingly relevant in Zambia's growing healthcare landscape.

Questions
100
Est. time
~100 min
Views
0
Pass mark
50%

How this revision works

Outcomes

If you passExcellent work! You have demonstrated a strong understanding of tumour antigens, a cornerstone of cancer immunology. This knowledge will serve you well in advanced studies and clinical applications. Keep pushing forward—you are building a solid foundation for a successful career in biomedical sciences.
If you don't pass yetThis topic is challenging, but do not be discouraged. Review the distinctions between TSTAs and TATAs, and consider how mutations and gene reactivation contribute to antigenicity. Revisit the lecture notes, discuss with peers, and attempt practice questions. Persistence is key to mastering complex immunological concepts—you can do this.

More in this course